Next Frontier Biosciences, LLC – Trademark Portfolio
Entity Type: 16
Next Frontier Biosciences, LLC has 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include VERRA. The portfolio includes 1 registered trademark. Filings span 3 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 3 (Cosmetics & Cleaning). This trademark owner is based in Denver, CO.
4910 Fox Street, Unit F
Denver, CO 80216
Showing of trademarks Trademarks
Trademark Classifications
Next Frontier Biosciences, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Next Frontier Biosciences, LLC have?
Next Frontier Biosciences, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.
What trademark classes does Next Frontier Biosciences, LLC file in?
Next Frontier Biosciences, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Next Frontier Biosciences, LLC's most well-known trademarks?
Next Frontier Biosciences, LLC's registered trademark portfolio includes well-known marks such as VERRA. These are among 1 currently registered trademark in the portfolio.
What is Next Frontier Biosciences, LLC's trademark registration success rate?
Next Frontier Biosciences, LLC has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.